Erlocip 150 mg
Erlocip 150 mg Tablet is an anticancer medicine used for the treatment of non-small cell lung cancer. It is also used in a combination with gemcitabine to treat pancreatic cancer.
Description Of Erlocip 150mg
Erlocip 150mg Tablet is an anticancer medicine used for the treatment of non-small cell lung cancer. It is also used in a combination with gemcitabine to treat pancreatic cancer. This medicine is not recommended for use in patients less than 18 years of age.
Erlocip 150mg Chemical Name
Erlocip 150mg Manufacturer
- Cipla Ltd
Uses of Erlocip 150mg
Erlocip 150mg tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer.
What is Erlocip 150mg?
Erlocip 150mg Tablet is used for Non-small cell lung cancer, Pancreatic cancer and other conditions. Erlocip 150mg Tablet may also be used for purposes not listed in this medication guide.
How Erlocip 150mg working?
Erlocip 150mg tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
How is Erlocip 150mg used?
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Erlocip 150mg tablet is to be taken empty stomach.
Erlocip 150mg Indications
Take this medicine as instructed by the doctor. You are advised to take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Erlocip 150mg Dosage
- Erlocip 100mg
- Erlocip 150mg
Contraindication Of Erlocip 150mg
Hypersensitivity to Erlocip 150mg Tablet is a contraindication. In addition, Erlocip 150mg Tablet should not be used if you have the following conditions:
- Children and adolescents under 18 years of age
- Gastrointestinal perforation
- Pulmonary disease
Adverse effects Of Erlocip 150mg
- Burning or tingling sensation
- Lower back or side pain
- Chills and fever
- Blurred vision
- Convulsions (seizures)
- Chest pain or discomfort
- Acid or sour stomach
- Hair loss
- Loss of appetite
Special Precautions And Related Warnings Of Erlocip 150mg
Erlocip 150mg tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Erlocip 150mg tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Erlocip 150mg tablet is safe to use in patients with kidney disease. No dose adjustment of Erlocip 150mg tablet is recommended. Use of this medicine is not advised in patients with severe kidney disease.
Erlocip 150mg tablet should be used with caution in patients with liver disease. Dose adjustment of Erlocip 150mg tablet may be needed. Please consult your doctor.
Storage Conditions for Erlocip 150mg
You should store your Erlocip 150mg below 25°C in a cool dry place.